15-Year Check-In: did the 'Smart' immune cells protect transplanted kidneys?
NCT ID NCT05987527
First seen Jan 05, 2026 · Last updated May 02, 2026 · Updated 21 times
Summary
This study follows 11 kidney transplant patients who previously received a personalized cell therapy (TX200-TR101) designed to prevent organ rejection. Researchers will monitor their health and kidney function for up to 15 years to see if the therapy remains safe and helps protect the transplanted kidney. The goal is to gather long-term safety data, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Erasmus MC, University Medical Center
Rotterdam, Netherlands
-
Leiden University Medical Centre
Leiden, Netherlands
-
Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom
-
University Hospitals Leuven
Leuven, Belgium
-
University Medical Center Groningen
Groningen, Netherlands
Conditions
Explore the condition pages connected to this study.